Section Arrow
AIDX.NASDAQ
- 20/20 Biolabs, Inc.
(Financial Status)
Quotes are at least 15-min delayed:2026/08/05 16:55 EDT
After Hours
Last
 0.4304
-0.0109 (-2.47%)
Bid
0.4304
Ask
0.4414
High 0.454 
Low 0.4304 
Volume 793 
Regular Hours (Closed)
Last
 0.4413
-0.0147 (-3.22%)
Day High 
0.4599 
Prev. Close
0.456 
1-M High
0.649 
Volume 
68.76K 
Bid
0.4304
Ask
0.4414
Day Low
0.4304 
Open
0.4599 
1-M Low
0.4011 
Market Cap 
5.59M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 0.46 
20-SMA 0.51 
50-SMA 0.66 
52-W High 50 
52-W Low 0.4011 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.49/-0.38
Enterprise Value
6.69M
Balance Sheet
Book Value Per Share
0.21
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
2.05M
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
BJDXBluejay Diagnostics Inc.1.24+0.24+24.00%-- 
After Hours 1.23 -0.01 -0.81%
BSXBoston Scientific Corp47.74-1.35-2.75%20.57PE
After Hours 48.7 +0.96 +2.01%
AMIXAutonomix Medical Inc.12.1-7.4-37.95%-- 
After Hours 11.39 -0.71 -5.87%
ADGMAdagio Medical Holdings Inc.0.739-0.061-7.63%-- 
After Hours 0.6801 -0.0589 -7.97%
PACBPacific Biosciences of California1.3-0.14-9.72%-- 
After Hours 1.25 -0.05 -3.85%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
20/20 Biolabs Inc is a commercial stage diagnostics company with the core mission of developing and commercializing clinical laboratory tests for early disease detection and prevention and associated software that is powered by machine learning and real-world data to improve diagnostic accuracy and clinical utility. The company offers two OneTest lab products; OneTest for Cancer that inludes primary MCED blood test and revenue source post-COVID and OneTest for Longevity thatconsists of inflammatory biomarkers.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.